Loading clinical trials...
Loading clinical trials...
Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Pump Cetaphil® DermaControl™ Moisturizer SPF 30, and Cetaphil® DermaControl™ Foaming Wash Regimen in Patients With Mild to Moderate Acne Vulgaris
Conditions
Interventions
Adapalene/BPO Gel
Moisturizer SPF 30
+1 more
Locations
5
United States
Study Protocol, Inc.
Boynton Beach, Florida, United States
Tennessee Clinical Research Center
Nashville, Tennessee, United States
Stephens & Associates
Carrollton, Texas, United States
J&S Studies, Inc.
College Station, Texas, United States
The Dermatology Clinical Research Center of San Antonio
San Antonio, Texas, United States
Start Date
October 1, 2013
Primary Completion Date
March 1, 2014
Completion Date
March 1, 2014
Last Updated
August 23, 2022
NCT07058883
NCT07406893
NCT07368764
NCT07205107
NCT07151599
NCT05639933
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions